母体艾滋病病毒感染与乳汁微生物群。

IF 13.8 1区 生物学 Q1 MICROBIOLOGY
Nicole H Tobin, Fan Li, Sean Brummel, Patricia M Flynn, Sufia Dababhai, Dhayendre Moodley, Lameck Chinula, Avy Violari, Mary Glenn Fowler, Vanessa Rouzier, Louise Kuhn, Grace M Aldrovandi
{"title":"母体艾滋病病毒感染与乳汁微生物群。","authors":"Nicole H Tobin, Fan Li, Sean Brummel, Patricia M Flynn, Sufia Dababhai, Dhayendre Moodley, Lameck Chinula, Avy Violari, Mary Glenn Fowler, Vanessa Rouzier, Louise Kuhn, Grace M Aldrovandi","doi":"10.1186/s40168-024-01843-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Children born to women with HIV but who do not become HIV infected experience increased morbidity and mortality compared with children born to women without HIV. The basis of this increased vulnerability is unknown. The microbiome, specifically the infant gut microbiome, likely plays an important role in infant immune development. The human milk microbiome is thought to have an important role in the development of the infant gut and therefore, if perturbed, may contribute to this increased vulnerability. We investigated the effects of HIV and its therapies on the milk microbiome and possible changes in the milk microbiome before or after infant HIV infection.</p><p><strong>Results: </strong>Seven-hundred fifty-six human milk samples were selected from three separate studies conducted over a 15-year period to investigate the role of HIV and its therapies on the human milk microbiome. Our data reveal that the milk microbiome is modulated by parity (R<sup>2</sup> = 0.006, p = 0.041), region/country (R<sup>2</sup> = 0.014, p = 0.007), and duration of lactation (R<sup>2</sup> = 0.027-0.038, all p < 0.001). There is no evidence, however, using 16S rRNA V4 amplicon sequencing, that the human milk microbiome is altered by HIV infection (R<sup>2</sup> = 0.003, p = 0.896), by combination antiretroviral therapy (R<sup>2</sup> = 0.0009, p = 0.909), by advanced maternal disease (R<sup>2</sup> = 0.003, p = 0.263), or in cases of infant infection either through isolated early mucosal (R<sup>2</sup> = 0.003, p = 0.197) or early mucosal and breast milk transmission (R<sup>2</sup> = 0.002, p = 0.587).</p><p><strong>Conclusions: </strong>The milk microbiome varies by stage of lactation, by parity, and by region; however, we found no evidence that the human milk microbiome is altered by maternal HIV infection, disease severity, or antiretroviral therapy. Additionally, we found no association between the milk microbiome and transmission of HIV to the infant. Investigations including higher resolution microbiome approaches or into other potential mechanisms to understand why the approximately one million children born annually to women with HIV escape infection, but do not escape harm, are urgently needed. Video Abstract.</p>","PeriodicalId":18447,"journal":{"name":"Microbiome","volume":"12 1","pages":"182"},"PeriodicalIF":13.8000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439335/pdf/","citationCount":"0","resultStr":"{\"title\":\"Maternal HIV infection and the milk microbiome.\",\"authors\":\"Nicole H Tobin, Fan Li, Sean Brummel, Patricia M Flynn, Sufia Dababhai, Dhayendre Moodley, Lameck Chinula, Avy Violari, Mary Glenn Fowler, Vanessa Rouzier, Louise Kuhn, Grace M Aldrovandi\",\"doi\":\"10.1186/s40168-024-01843-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Children born to women with HIV but who do not become HIV infected experience increased morbidity and mortality compared with children born to women without HIV. The basis of this increased vulnerability is unknown. The microbiome, specifically the infant gut microbiome, likely plays an important role in infant immune development. The human milk microbiome is thought to have an important role in the development of the infant gut and therefore, if perturbed, may contribute to this increased vulnerability. We investigated the effects of HIV and its therapies on the milk microbiome and possible changes in the milk microbiome before or after infant HIV infection.</p><p><strong>Results: </strong>Seven-hundred fifty-six human milk samples were selected from three separate studies conducted over a 15-year period to investigate the role of HIV and its therapies on the human milk microbiome. Our data reveal that the milk microbiome is modulated by parity (R<sup>2</sup> = 0.006, p = 0.041), region/country (R<sup>2</sup> = 0.014, p = 0.007), and duration of lactation (R<sup>2</sup> = 0.027-0.038, all p < 0.001). There is no evidence, however, using 16S rRNA V4 amplicon sequencing, that the human milk microbiome is altered by HIV infection (R<sup>2</sup> = 0.003, p = 0.896), by combination antiretroviral therapy (R<sup>2</sup> = 0.0009, p = 0.909), by advanced maternal disease (R<sup>2</sup> = 0.003, p = 0.263), or in cases of infant infection either through isolated early mucosal (R<sup>2</sup> = 0.003, p = 0.197) or early mucosal and breast milk transmission (R<sup>2</sup> = 0.002, p = 0.587).</p><p><strong>Conclusions: </strong>The milk microbiome varies by stage of lactation, by parity, and by region; however, we found no evidence that the human milk microbiome is altered by maternal HIV infection, disease severity, or antiretroviral therapy. Additionally, we found no association between the milk microbiome and transmission of HIV to the infant. Investigations including higher resolution microbiome approaches or into other potential mechanisms to understand why the approximately one million children born annually to women with HIV escape infection, but do not escape harm, are urgently needed. Video Abstract.</p>\",\"PeriodicalId\":18447,\"journal\":{\"name\":\"Microbiome\",\"volume\":\"12 1\",\"pages\":\"182\"},\"PeriodicalIF\":13.8000,\"publicationDate\":\"2024-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439335/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbiome\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1186/s40168-024-01843-8\",\"RegionNum\":1,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbiome","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1186/s40168-024-01843-8","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:与未感染艾滋病毒的妇女所生子女相比,感染艾滋病毒但未感染艾滋病毒的妇女所生子女的发病率和死亡率均有所上升。这种脆弱性增加的原因尚不清楚。微生物组,特别是婴儿肠道微生物组,可能在婴儿免疫发育中发挥重要作用。人乳微生物组被认为在婴儿肠道发育中起着重要作用,因此,如果受到干扰,可能会导致这种脆弱性的增加。我们研究了 HIV 及其疗法对牛奶微生物组的影响,以及婴儿感染 HIV 前后牛奶微生物组可能发生的变化:我们从三项历时 15 年的独立研究中选取了 756 份母乳样本,以调查 HIV 及其疗法对母乳微生物组的影响。我们的数据显示,牛奶微生物组受以下因素的影响:胎次(R2 = 0.006,p = 0.041)、地区/国家(R2 = 0.014,p = 0.007)、哺乳期(R2 = 0.027-0.038,所有 p 2 = 0.003,p = 0.896)、联合抗逆转录病毒疗法(R2 = 0.0009,p = 0.909)、晚期母体疾病(R2 = 0.003,p = 0.263)或婴儿通过隔离的早期粘膜感染(R2 = 0.003,p = 0.197)或早期粘膜和母乳传播(R2 = 0.002,p = 0.587):乳汁微生物组因哺乳期、胎次和地区而异;但是,我们没有发现任何证据表明人类乳汁微生物组会因母体感染艾滋病毒、疾病严重程度或抗逆转录病毒治疗而改变。此外,我们也没有发现母乳微生物群与婴儿感染艾滋病病毒之间有任何联系。我们急需开展包括更高分辨率微生物组方法或其他潜在机制在内的研究,以了解为什么每年约有 100 万名感染 HIV 的妇女所生的孩子逃过了感染,但却没有逃过伤害。视频摘要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Maternal HIV infection and the milk microbiome.

Background: Children born to women with HIV but who do not become HIV infected experience increased morbidity and mortality compared with children born to women without HIV. The basis of this increased vulnerability is unknown. The microbiome, specifically the infant gut microbiome, likely plays an important role in infant immune development. The human milk microbiome is thought to have an important role in the development of the infant gut and therefore, if perturbed, may contribute to this increased vulnerability. We investigated the effects of HIV and its therapies on the milk microbiome and possible changes in the milk microbiome before or after infant HIV infection.

Results: Seven-hundred fifty-six human milk samples were selected from three separate studies conducted over a 15-year period to investigate the role of HIV and its therapies on the human milk microbiome. Our data reveal that the milk microbiome is modulated by parity (R2 = 0.006, p = 0.041), region/country (R2 = 0.014, p = 0.007), and duration of lactation (R2 = 0.027-0.038, all p < 0.001). There is no evidence, however, using 16S rRNA V4 amplicon sequencing, that the human milk microbiome is altered by HIV infection (R2 = 0.003, p = 0.896), by combination antiretroviral therapy (R2 = 0.0009, p = 0.909), by advanced maternal disease (R2 = 0.003, p = 0.263), or in cases of infant infection either through isolated early mucosal (R2 = 0.003, p = 0.197) or early mucosal and breast milk transmission (R2 = 0.002, p = 0.587).

Conclusions: The milk microbiome varies by stage of lactation, by parity, and by region; however, we found no evidence that the human milk microbiome is altered by maternal HIV infection, disease severity, or antiretroviral therapy. Additionally, we found no association between the milk microbiome and transmission of HIV to the infant. Investigations including higher resolution microbiome approaches or into other potential mechanisms to understand why the approximately one million children born annually to women with HIV escape infection, but do not escape harm, are urgently needed. Video Abstract.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Microbiome
Microbiome MICROBIOLOGY-
CiteScore
21.90
自引率
2.60%
发文量
198
审稿时长
4 weeks
期刊介绍: Microbiome is a journal that focuses on studies of microbiomes in humans, animals, plants, and the environment. It covers both natural and manipulated microbiomes, such as those in agriculture. The journal is interested in research that uses meta-omics approaches or novel bioinformatics tools and emphasizes the community/host interaction and structure-function relationship within the microbiome. Studies that go beyond descriptive omics surveys and include experimental or theoretical approaches will be considered for publication. The journal also encourages research that establishes cause and effect relationships and supports proposed microbiome functions. However, studies of individual microbial isolates/species without exploring their impact on the host or the complex microbiome structures and functions will not be considered for publication. Microbiome is indexed in BIOSIS, Current Contents, DOAJ, Embase, MEDLINE, PubMed, PubMed Central, and Science Citations Index Expanded.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信